Sousa, A.C.; Biscaia, S.; Alvites, R.; Branquinho, M.; Lopes, B.; Sousa, P.; Valente, J.; Franco, M.; Santos, J.D.; Mendonça, C.;
et al. Assessment of 3D-Printed Polycaprolactone, Hydroxyapatite Nanoparticles and Diacrylate Poly(ethylene glycol) Scaffolds for Bone Regeneration. Pharmaceutics 2022, 14, 2643.
https://doi.org/10.3390/pharmaceutics14122643
AMA Style
Sousa AC, Biscaia S, Alvites R, Branquinho M, Lopes B, Sousa P, Valente J, Franco M, Santos JD, Mendonça C,
et al. Assessment of 3D-Printed Polycaprolactone, Hydroxyapatite Nanoparticles and Diacrylate Poly(ethylene glycol) Scaffolds for Bone Regeneration. Pharmaceutics. 2022; 14(12):2643.
https://doi.org/10.3390/pharmaceutics14122643
Chicago/Turabian Style
Sousa, Ana Catarina, Sara Biscaia, Rui Alvites, Mariana Branquinho, Bruna Lopes, PatrÃcia Sousa, Joana Valente, Margarida Franco, José Domingos Santos, Carla Mendonça,
and et al. 2022. "Assessment of 3D-Printed Polycaprolactone, Hydroxyapatite Nanoparticles and Diacrylate Poly(ethylene glycol) Scaffolds for Bone Regeneration" Pharmaceutics 14, no. 12: 2643.
https://doi.org/10.3390/pharmaceutics14122643
APA Style
Sousa, A. C., Biscaia, S., Alvites, R., Branquinho, M., Lopes, B., Sousa, P., Valente, J., Franco, M., Santos, J. D., Mendonça, C., Atayde, L., Alves, N., & MaurÃcio, A. C.
(2022). Assessment of 3D-Printed Polycaprolactone, Hydroxyapatite Nanoparticles and Diacrylate Poly(ethylene glycol) Scaffolds for Bone Regeneration. Pharmaceutics, 14(12), 2643.
https://doi.org/10.3390/pharmaceutics14122643
